Latest drug medicine Tenders | Government drug medicine Tenders

corporations/Associations/Others

CTN :44434766

12 May, 2026 NA

Delhi - Delhi

Tender For corrigendum : supply of drugs/medicines - metoclopramide inj- each ml to contain: metoclopramide hcl eqv. to metoclopramide 5 mg packing: 2ml amp, promethazine syp-each 5 ml to contain: promethazine 5mg packing: 100ml bottle, promethazine inj-each ml to contain: promethazine 25mg, packing: 2ml vial/amp, artificial tears drop-each vial to contain: polyvinyl alcohol 1.4%, povidone 0.6%, benzalkonium chloride 0.01%packing:10ml vial, sodium hyaluronate inj (intra articular)-each pfs to contain: sodium hyaluronate 25mg, sodium chloride, sodium phosphate dibasic and monobasic q.s., packing: 1 pfs, tropicamide eye drop-each vial to contain: tropicamide 0.8%, phenyl ephrine hcl 5% packing:5ml vial, ibuprofen oral susp-each 5 ml to contain: ibuprofen 100 mg packing:60ml bottle, indomethacin tab/cap-each tab/cap to contain: indomethacin 25 mg, indomethacin sr tab/cap-each sr tab/cap to contain: indomethacin 75 mg, antibiotic eye oint-each gram to contain: polymyxin b sulphate 5000 iu, neomycin sulphate 3400 iu, zinc bacitracin 400 iu, hydrocortisone 10 mg in white sterilised petroleum jelly base.packing:5gm tube, flurbiprofen eye drop-each vial to contain: flurbiprofen 0.03% w/v packing:5ml vial, polymixin, neomycin eye oint-each gm to contain: polymixin b sulphate 5000 iu, neomycin sulphate 3400 iu, zinc bacitracin 400 iu 5gm to 10gm tube, antacid gel-each 5ml to contain: aluminium hydroxide 6g, mag. hydroxide 80mg., activated dimethicone 100mg, deglycycrrhizinated liquorice eqv. to liquorice 400mg.,packing: 180ml bottle, otilonium bromide tab/cap-each tab/cap to contain: otilonium bromide 40mg, euphorbia prostata tab/cap -each tab/cap to contain: euphorbia prostata dry extract ethanolic 80% (v/v) 100mg, paracetamol inj -each ml to contain: paracetamol 10 mg,100ml bottle, dorzolamide+timolol eye drop-each vial to contain: dorzolamide 2% ,timolol i.p. 0.5%, packing:5ml vial, tocilizumab inj 80mg -each vial to contain: tocilizumab 80 mg, packing: 4ml vial, tocilizumab inj 200mg -each vial to contain: tocilizumab 200 mg, packing: 10ml vial, tocilizumab inj 400mg -each vial to contain: tocilizumab 400 mg, packing: 20ml vial, racecadotril dispersible tab/cap-each disp tab/cap to contain: racecadotril 10mg, racecadotril dispersible tab/cap-each disp tab/cap to contain: racecadotril 30mg, haemorrhoidal cream-each gm to contain: euphorbia prostrata dry extract ethanolic 80% (v/v)((35-70):1) 10 mg (containing 0.315 -0.825 mg total flavonoids calculated as apigenin-7 glucoside and 1.26-4.40 mg total phenolics calculated as gallic acid)cream base q.s.packing:30gm tube, buprenorphine transdermal patch - each transdermal patch to contain :buprenorphine 5 mcg/hr. area containing active substance 6.25sqcm,6.25sqcm patch, buprenorphine transdermal patch - each transdermal patch to contain : buprenorphine 10 mcg/hr. area containing active substance 12.5sqcm,12.5sqcm patch, buprenorphine transdermal patch - each transdermal patch to contain :buprenorphine 20 mcg/hr. area containing active substance 25sqcm,25sqcm patch, analgesic cream-each tube to contain: methyl salicylate 30% w/w, menthol 10% w/w, camphor 4 % w/w, excipients q.s. packing:30 gm tube, misoprostol tab/cap-each tab/cap to contain : misoprostol 25mcg, dorzolamide eye drop-each vial to contain: dorzolamide 2% packing:5ml vial, metronidazole oral gel-each tube to contain: metronidazole 1%, chlorhexidine 0.25% packing:20gm tube, prucalopride tab/cap-each tab/cap to contain: prucalopride 1mg, pancreatin + activated dimethicone tab/cap-each enteric coated tab/cap to contain: pancreatin 170mg, activated dimethicone 80mg, lubricating eye drop-each vial to contain: povidone 20mg/ml, preservative free, phosphate free, packing: 10ml vial, antacid syp-each 5ml to contain: aluminium hydroxide paste eqv. to dried aluminium hydroxide gel i.p 300 mg, magnesium hydroxide paste eqv. to magnesium hydroxide i.p 250 mg, activated dimethicone i.p 40mg, sorbitol solution i.p 1000mg,170ml bottle, essential phosp

corporations/Associations/Others

CTN :44434772

12 May, 2026 NA

Delhi - Delhi

Tender For corrigendum : supply of drugs/medicines - 5-aminosalicylic acid (mesalazine/ mesalaine) retention enema: each 60ml unit of rectal suspension contains mesalazine/mesalamine 4.0 gramspacking:60ml bottle, mesalazine/ mesalaine suppository-each suppository to contain: mesalazine/ mesalaine 500mg, mercaptopurine tablet-each tab to contain: mercaptopurine 50mg, abacavir + lamivudine tablet: each tab to contain: abacavir 60 mg + lamivudine 30 mg, abacavir + lamivudine tablet: each tab to contain: abacavir 600 mg + lamivudine 300 mg, abacavir tablet: each tablet to contain: abacavir 60mg, acetyl salicylic acid tab-each enteric coated tablet to contain: acetyl salicylic acid 100mg, actinomycin d inj-each vial to contain: actinomycin d 0.5mg packing:1 vial, activated charcoal powder packing:100gm, acyclovir inj-each vial to contain: acyclovir 250mg packing:1 vial, acyclovir oral suspension-each 5ml to contain: acyclovir 400 mg, packing:100ml bottle, acyclovir tab-each tablet to contain: acyclovir 800mg., allopurinol tab -each tablet to contain: allopurinol 300 mg, all-trans retinoic acid cap-each capsule to contain all trans retinoic acid 10mg, alprostadil inj- each ml to contain alprostadil 500mcg packing:1ml vial/amp, amoxycillin oral suspension - each 5 ml to contain: amoxycillin 250 mg, packing:100ml bottle, amoxicillin inj-each vial to contain: amoxicillin 1000 mg packing:1 vial, amoxicillin inj-each vial to contain: amoxicillin 250 mgpacking:1 vial, amoxicillin inj-each vial to contain: amoxicillin 500 mg packing:1 vial, lipid amphotericin b inj-each vial to contain: lipid amphotericin b 50 mg packing:1 vial, ampicillin inj-each vial to contain: ampicillin 1000 mg(1gm) packing:1 vial, arsenic trioxide inj-each ml to contain arsenic trioxide 1mg packing:10ml vial, artemether & lumefantrine tablet-each tablet to contain: artemether 40mg and lumefantrine 240mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 150mg (b)2 tablets of sulphadoxine 500mg & pyrimethamine 25mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 25mg (b) 1 tablet of sulphadoxine 250mg & pyrimethamine 12.5mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 50mg (b) 1 tablet of sulphadoxine 500mg & pyrimethamine 25mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 100mg (b) 1 tablet of sulphadoxine 750mg & pyrimethamine 37.5mg, artesunate inj- each vial to contain:artesunate 120 mg packing:1 vial, atazanavir + ritonavir tab-each tablet to contain atazanavir 300 mg+ritonavir 100 mg, atropine eye drop: each ml to contain atropine 1% packing:5ml vial, azathioprine tab-each tablet to contain: azathioprine 25 mg, baclofen tab-each tablet to contain: baclofen 20 mg, barium sulphate oral liquid-barium sulphate 95% w/v, packing:500ml bottle, bedaquilinetab-each tablet to contain: bedaquiline 100 mg, bendamustine inj-each vial to contain: bendamustine hydrochloride 25mg packing:1 vial, betamethasone valerate cream- each gm to contain betamethasone valerate0.05 %packing:15gm tube, betamethasone valerate cream- each gm to contain betamethasone valerate 0.1%packing:15gm tube, bisacodyl suppository-each suppository to contain: bisacodyl 5mg, bisacodyl tab--each tablet to contain: bisacodyl 5 mg, budesonide nasal spray-each actuation to deliver: budesonide 50 mcg. packing:100 to 150 doses, bupivacaine injection 0.5 % with 7.5 % glucose packing:4ml amp, caffeine inj-each ml to contain: caffeine citrate 20mg packing: 2ml vial/amp, caffeine oral solution- each ml to contain: caffeine citrate 20mg packing: 3 ml bottle, calcium carbonate tablet- each tablet to contain calcium carbonate 625 mg (equivalent to elemental calcium 250 mg), calcium folinate inj-each ml to contain: calcium folinate 3mg packing: 1ml vial/amp, calcium folinate tab-each tab to contain: calcium folinate 15mg, carbamazepine oral liquid-each 5ml to contain: carbamazepine 100mg, packing:100 ml bottle, c

corporations/Associations/Others

CTN :44434778

12 May, 2026 NA

Delhi - Delhi

Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin inj-each vial to contain: bleomycin ip 15iu, vincristine inj-each vial to contain: vincristine ip 1mg, doxorubicin inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid inj-each vial to contain: zoledronic acid 4mg, octreotide inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte inj-each inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap

corporations/Associations/Others

CTN :44434780

12 May, 2026 NA

Delhi - Delhi

Tender For corrigendum : supply of drugs/medicines - medroxy progesterone inj-each ml to contain: medroxy progesterone acetate suspn.150mg., packing:1ml vial, norethisterone tab/cap-each tab/cap to contain: norethisterone 5mg., streptomycin inj-each vial to contain: streptomycin sulphate 0.75gm, streptomycin inj-each vial to contain: streptomycin sulphate 1gm, ampicillin dry syp-each 5ml to contain: ampicillin 125mg packing: 30ml bottle, pyrazinamide kid plain/dispersible tab/cap each kid plain/dispersible tab/cap to contain: pyrazinamide300mg, chloroquine syp-each 5ml to contain: chloroquine phosphate 50mg. packing: 60ml bottle, chloroquine inj-each ml to contain: chloroquine phosphate eqv. to chloroquine base 40mg., packing:5ml amp, quinine tab/cap-each tab/cap to contain: quinine sulphate 300mg., quinine inj-each ml to contain: quinine 300mg., 2ml amp, vecuronium inj-each vial/amp to contain: vecuronium 4mg, dextrose inj-each amp to contain: dextrose anhydrous 25% w/v., packing:25ml amp, cefpirome inj-each vial to contain: cefpirome 1 gm., vancomycin inj-each vial to contain: vancomycin hcl. eqv. to vancomycin 500mg. packing: 1 vial, lamivudine tab/cap-each tab/cap to contain: lamivudine 150mg., nevirapine tab/cap-each tab/cap to contain: nevirapine 200mg., rifampicin tab/cap- each tab/cap to contain: rifampicin 600mg., isoflurane-each 100ml to contain: isoflurane, packing:100ml bottle, methylprednisolone sod. succinate inj-each vial/amp to contain: methylprednisolone sod. succinate 40 mg packing:1ml vial/amp, rifampicin & inh tab/cap-each tab/cap to contain: isoniazide 50mg., rifampicin 100mg, cabergoline tab/cap-each tab/cap to contain: cabergoline 0.5mg., methylprednisolone acetate inj-each vial to contain: methyl prednisolone acetate 40mg., medroxy progesterone tab/cap-each tab/cap to contain: medroxy progesterone acetate 10 mg, clomiphen citrate tab/cap-each tab/cap to contain: clomiphen citrate 50 mg., betamethasone inj-each ml to contain: betamethasone ip 4mg., packing:1ml amp, dexamethasone tab/cap-each tab/cap to contain: dexamethasone 0.5 mg., nandrolone inj-each ml to contain: nandrolone phenyl propionate 25 mg., packing:1ml amp, chloramphenicol inj-each vial to contain: chloramphenicol sod. succinate eqv. to chloramphenicol 1gm, rifampicin syp-each 5 ml to contain: rifampicin 100 mg., packing: 100ml bottle, thiopentone sodium inj-each vial to contain: thiopentone sodium ip 0.5 gm., fentanyl inj-each ml to contain: fentanyl 50mcg. packing: 2ml amp, polymer of degraded gelatin (for iv infusion)- each bottle to contain: polymer of degraded gelatin3.5 gm. electrolytes & distilled water to 100 ml per 100 ml,packing:500ml bottle, potassium chloride inj-each ml to contain: potassium chloride i.p. 0.15 gm packing: 10ml amp, methylprednisolone sod. succinate inj-each vial to contain: methyl prednisolone sod. succinate 125mg., levonorgestrel tab/cap-each tab/cap to contain: levonorgestrel i.p. 0.75mg, cefixime + lactobacillus syp-each 5ml to contain: cefixime 50mg, lactic acid bacillus 30 million spores,30ml bottle, medroxy- progesterone inj-each ml to contain: medroxy- progesterone acetate 150mg, packing:1ml pfs, clarithromycin inj-each vial to contain: clarithromycin 500mg packing: 1 vial, insulin aspart inj-each vial to contain: insulin aspart (r-dna origin) packing:10ml vial, sitagliptin tab/cap-each tab/cap to contain: sitagliptin 100mg, ertapenem sodium inj-each vial to contain: ertapenem 1 gm (equ. to ertapenem sod.1.046 gm.) iv / im packing: 1 vial, acyclovir inj-each vial to contain: acyclovir 500mg, liraglutide inj-inj human glp-1 analogue contains: liraglutide 6mg / ml, packing:3ml inj, insulin detemir inj-each inj to contain: insulin detemir 100 iu/ml (r- dna) packing: 3ml cartridge, human interferon beta 1a inj -each vial/pfs to contain: recombinant human interferon beta 1a 44mcg, saxagliptin tab/cap-each tab/cap to contain: saxagliptin 5mg, colistimethate sodium inj-each vial to contain: colistimethate sodium b

corporations/Associations/Others

CTN :44434787

12 May, 2026 NA

Delhi - Delhi

Tender For corrigendum : supply of drugs/medicines - methyl ergometrine maleate inj-each ml to contain: methyl ergometrine maleate 0.2mg. packing: 1 amp, pheniramine tab/cap-each tab/cap to contain: pheniramine maleate 25mg., pheniramine maleate inj-each ml to contain: pheniramine maleate 22.75mg. packing: 2ml amp, benzyl benzoate application-each bott to contain:benzyl benzoate 25% packing:1000ml bottle, framycetin skin cream-each tube to contain: framycetin sulphate 1%,30gm tube, white soft paraffin-each pack to contain: white soft paraffin packing:500gm, vitamin inj-each 2ml to contain: thiamine 10mg. riboflavin 4 mg. nicotinamide 40 mg. cyanocobalamine 8 mcg. pyridoxine 4mg. d- panthenol 6mg. benzyl alcohol 0.9% packing:2ml amp, methyl ergometrine tab/cap-each tab/cap to contain: methyl ergometrine 0.125mg., silver sulphadiazine oint each tube to contain: silver sulphadiazine 1%, chlorhexidinegluconate 0.2%, aloe vera 15%, allantoin 0.1% packing: 15gm tube, erythropoietin inj-each vial/multidose pfp to contain: recombinant human erythropoietin 20000 units, isoxsuprine sr tab/cap-each sr tab/cap to contain: isoxsuprine hcl 40 mg., carboprost inj-each ml to contain: carboprost 0.25mg. packing:1ml amp, allylestrenol tab/cap-each tab/cap to contain : allylestrenol 5 mg., framycetin cream-each tube to contain: framycetin sulphate 1% w/w,100gm tube, glycerine-each bott to contain: glycerine 500 gm packing:500gm bottle, multi vitamin inj (for iv infusion)-each 10ml to contain : vit.c 500 mg, vit. a 10,000 iu, vit. b1 50 mg, nicotinamide 100 mg, vit. b6 15 mg, d- panthenol 25 mg, alpha-tocopheryl acetate 5 mg, vit. d 1000 iu, vit. b2 14 mg,packing:10ml vial/amp, aminoacid and iron syp-each 10ml to contain: l-histidine hcl 4 mg, l-lysine hcl 25 mg,thiamine hcl 5 mg, riboflavin 3 mg, nicotinamide 25 mg, pyridoxin hcl 1.5 mg, cyanocobalamin 2.5 mcg, folic acid 0.5 mg, ascorbic acid 40.0 mg, d-panthenol 2.5 mg, ferrous glycine sulphate 275 mg,200ml bottle, mifepristone tab/cap-each tab/cap to contain: mifepristone 200mg, gbhc cream-each tube to contain: gbhc 1%, benzocaine 2%, cream base, packing:25gm tube, natural micronised progesterone tab/cap-each tab/cap to contain: natural micronised progesterone ip 100 mg, somatropin (r-dna) inj-each pfs contain: somatropin (r-dna) origin bio- synthetic human growth hormone solution 10mg/1.5ml=30 iu, hydroquinone + tretinoin + mometasone cream each tube to contain: hydroquinone ip/bp/usp 2.0% w/w,tretinoin ip/bp/usp 0.025% w/w,mometasone furoate ip/bp/usp 0.1% w/wpacking: 30gm tube, lidocaine spray-each pack to contain: spray lidocaine 1.0%, cetrimide 0.1%, polyvinyl polymer 2.8% solvent & propellent q.s.,packing:100gm, hydrogen peroxide-each bottle to contain: hydrogen peroxide ip, packing:400ml bottle, dexchlorpheniramine sr tab/cap- each sr tab/cap to contain: dexchlorpheniramine 6mg, sertaconazole nitrate lotion-each phial to contain: sertaconazole nitrate 2% w/v, propylene glycol base q.s. packing:15ml, desonide cream-each tube to contain: desonide 0.05%, packing:10gm tube, desonide lotion-each bottle to contain: desonide 0.05% w/w., packing:30ml bottle, calcium tab/cap-each tab/cap to contain: calcium citrate malate equivalent to elemental calcium 250mg, calcitriol 0.25 mcg,vitamin k2-7 50mcg., levonorgestrel-each sterile intrauterine system to contain: levonorgestrel 52mg (levonorgestrel 20 microgram / 24 hours intra uterine delivery system), follitropin alpha 1050iu/1.75ml inj-each vial to contain: follitropin alpha 1050iu/1.75ml, inj calcium gluconate-each ml to contain: calcium gluconate 100mg packing: 10ml vial, posaconazole soln-each phial to contain : posaconazole oral soln 40mg/ml packing:105 ml bottle, valethamate bromide inj-each ml to contain: valethamate bromide 8mg, hyaluronidase inj-each ml to contain: hyaluronidase i.p.(ovine)1500 i.u., prilocaine + lignocaine oint/cream/gel-each gm to contain: prilocaine 25mg, lignocaine 25mg, packing:5gm tube, pyridoxin tab/cap-each tab/cap to c

corporations/Associations/Others

CTN :44434788

12 May, 2026 NA

Delhi - Delhi

Tender For corrigendum : supply of drugs/medicines - methyldopa tab/cap-each tab/cap to contain: methyldopa 250mg, dopamine inj-each ml to contain: dopamine hcl 40 mg,5ml amp, isoxsuprine inj-each ml to contain: isoxsuprine 5mg packing:2ml vial/amp, flunarizine tab/cap-each tab/cap to contain: flunarizine 10mg, diazepam tab/cap-each tab/cap to contain: diazepam 5mg, imipramine tab/cap-each tab/cap to contain: imipramine 25mg, phenytoin sodium tab/cap-each tab/cap to contain: phenytoin sodium 100mg, dobutamine inj-each vial/amp to contain : dobutamine hcl. eqv. to dobutamine 250mg, ipratropium + salbutamol inhaler-each metered dose to contain: ipratropium i.p.20mcg., salbutamol i.p.100mcg packing:equal to or more than 120 mdi, metoprolol inj-each ml to contain: metoprolol 1mg packing:5ml vial/amp, amiodarone inj-each ml to contain: amiodarone 50mg, packing:3ml amp, vitamin k inj-each ml to contain: phytomenadione 10mg, packing:1ml vial/amp, salmeterol rotacap-each rotacap to contain : salmeterol i.p.50mcg, paediatric cough syp-each 5 ml to contain: promethazine hcl 1.5 mg, pholcodine 1.5 mg (as citrate), packing:60ml bottle, digoxin tab/cap-each tab/cap to contain: digoxin 0.25 mg, isoxsuprine tab/cap-each tab/cap to contain: isoxsuprine hcl 10 mg, haemostatic tab/cap-each tab/cap to contain: citrus bioflavonoid compound 150 mg, ascorbic acid 75 mg, menadione (vit.k) 0.66 mg, ferrous gluconate 67 mg, tribasic calcium phosp. 144.43 mg., nimodipine tab/cap-each tab/cap to contain: nimodipine 30 mg, sodium valproate syp-each 5ml to contain: sodium valproate i.p. 200 mg packing:100ml bottle, sodium valproate tab/cap -each tab/cap to contain: sodium valproate 200mg., levodopa & carbidopa tab/cap-each tab/cap to contain: levodopa 250 mg, carbidopa 25 mg, cough syp-each 5 ml to contain: methdilazine 2.5 mg , amm. chloride 100 mg, sodium citrate 50 mg, packing:115ml bottle, anti hemophillic inj - each vial to contain:anti hemophillic factor viii (non-recombinant)/ monoclonal purified - 250 iu, turbuhaler/inhaler -each metered dose to contain: budesonide 160 mcg, formoterol fumarate dihydrate 4.5 mcg, lactose monohydrate 730 mcg.(equal to or more than 60 doses), adenosine inj-each 2ml to contain: adenosine 6mg, packing:2ml amp, nicorandil sustained release tab/cap-each sustained release tab/cap to contain: nicorandil 20mg, fondaparinux sodium inj-each pfs to contain: fondaparinux sodium 2.5mg, vitamin k inj-each amp to contain: vitamin k ip 1.0 mg, packing:0.5ml amp, lorazepam tab/cap-each tab/cap to contain: lorazepam 1mg, phenobarbitone syp-each 5ml to contain: phenobarbitone 20mg, packing:60ml bottle, triclofos syp-each 5ml to contain: triclofos sodium bp 500mg, packing:30ml bottle, piracetam syp-each 5ml to contain: piracetam 500mg packing:100ml bottle, sumatriptan tab/cap-each tab/cap to contain: sumatriptan 50mg, zolpidem tartrate er tab/cap-each er tab/cap to contain: zolpidem tartrate 12.5 mg, tenecteplase 40mg inj-each vial to contain: tenecteplase 40mg, factor eight bypassing activity - containing : factor eight bypassing activity, anti-inhibitor-coagulant complex. 500 iu/u., recombinant anti hemophillic factor-viii -containing : recombinant anti hemophillic factor-viii 250 iu, ranolazine 500mg tab/cap each plain/sr/cr/dr/er/mrtab/cap to contain: ranolazine 500mg, labetalol inj-each ml to contain: labetalol hydrochloride 5mg, packing:4ml amp, bupripion er tab/cap -each er tab/cap to contain: bupripion 150mg, phenytoin sodium syp-each ml to contain: phenytoin sodium 25mg packing:100ml bottle, perindopril erbumine 8mg, amlodipine besilate equivalent to amlodipine 5mg excipients q.s. tab/cap-each uncoated tab/cap to contain:perindopril erbumine 8mg,amlodipine besilate equivalent to amlodipine 5mg excipients q.s., perindopril erbumine 8mg, indapamide 2.5mg excipients q.s. scored tab/cap -each uncoated scored tab/cap to contain: perindopril erbumine 8mg, indapamide 2.5mg excipients q.s., budesonide + levosalbutamol respule:each amp to con

Central Government/Public Sector

CTN :44828946

23 Apr, 2026 NA

Jaipur - Rajasthan

Tender For engagement of suppliers for supply of drugs/ medicines (generic medicines and ethical medicines)/ consumables at dispensary under administrative control of sbi, local head office, c-scheme, jaipur.

Central Government/Public Sector

CTN :44835882

23 Apr, 2026 NA

Jaipur - Rajasthan

Tender For engagement of suppliers for supply of drugs/ medicines (generic medicines and ethical medicines)/ consumables at dispensary under administrative control of sbi, local head office, c-scheme, jaipur.

CTN :44465342

23 Apr, 2026 NA

Varanasi - Uttar Pradesh

Tender For corrigendum : invitation of open tender for entering into rate contract with vendors i.e. firms/distributors/chemist shops for supply of all type of drugs/medicines on day-to- day basis to b.l.w. central hospital, varanasi, round the clock (i.e., 24*7), on the basis of uniform discount rate on mrpfor a period of twenty four months from the date of commencement of the rate contract.

State Government

CTN :44727152

15 Apr, 2026 9.90 Lacs

Barmer - Rajasthan

Tender For one year rate contract drug medicines for govt hospital barmer

Drug Medicine Tenders

By Cities

By States

By Agencies

By Ownerships

By Sectors